A Case of Male Breast Cancer Patient with CHEK2*1100delC Mutation

Male breast cancer (MBC) is a rare disease that accounts for less than one percent of all breast cancers. The association between BRCA1 and BRCA2 mutations and MBC has been well-established; recent data suggest that CHEK2 1100delC heterozygosity is also associated with an increased risk of MBC. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Quan D, Tavana, Anahita, Saenz Rios, Florentino, Posleman Monetto, Flavia E, Robinson, Angelica S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398738/
https://www.ncbi.nlm.nih.gov/pubmed/32766014
http://dx.doi.org/10.7759/cureus.8972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398738/
https://www.ncbi.nlm.nih.gov/pubmed/32766014
http://dx.doi.org/10.7759/cureus.8972

Ejemplares similares